Is Pain Reprocessing Therapy Legit?

Written By Rick Hamman

If you've spent any time in chronic pain forums lately, you've probably run into Pain Reprocessing Therapy, or PRT — a talk-therapy approach that treats certain kinds of chronic pain not as damage that needs fixing, but as a false alarm your brain has learned to sound. That's a big claim. No surgery, no medication, no injections — just roughly two months of structured conversation, and some people go from a decade of daily back pain to none at all.

Claims that bold deserve skepticism. So rather than take PRT's word for it, it's worth looking at what happened when researchers actually tested it in a randomized controlled trial — the gold standard for figuring out whether a treatment works or whether people just wanted it to. That trial is usually called the Boulder Back Pain Study, and it's the best evidence PRT has to offer.

What PRT actually claims

The theory behind PRT, developed by researchers including Alan Gordon and Yoni Ashar, is that a meaningful share of chronic pain — especially chronic back pain with no clear structural cause — isn't being generated by ongoing tissue damage. Instead, it's "neuroplastic pain": pain signals that were once useful (protecting an injury) but have become a learned pattern in the brain and nervous system, misfiring long after the original injury healed. If that's true, then pain can potentially be reduced by retraining the brain to stop overreacting to safe signals from the body, rather than by continuing to treat the back itself.

That's a testable hypothesis, and the Boulder Back Pain Study tested it.

The Boulder Back Pain Study: what was actually tested

The trial, formally titled "Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain," was led by Yoni Ashar and colleagues at the University of Colorado Boulder and published in JAMA Psychiatry in 2021 (PubMed listing).

The design was set up specifically to rule out the obvious objections — that people just felt better because they got attention, or because they believed they'd feel better. Researchers recruited 151 adults, average age 41, who had lived with chronic back pain for an average of about ten years, and randomly split them into three groups:

  • Pain Reprocessing Therapy (50 people): one evaluation session with a physician, then eight one-hour therapy sessions over four weeks, focused on reappraising pain sensations, testing feared movements, and addressing the emotional context around pain.

  • Placebo (51 people): an open-label saline injection at the site of pain, paired with education on the power of placebo — a rigorous control designed to isolate the effect of belief and attention alone.

  • Usual care (50 people): no new intervention, continuing whatever treatment they were already receiving.

The primary outcome was blunt and hard to spin: self-reported back pain intensity on a 0–10 scale.

What the results showed

The results were, frankly, larger than most chronic pain trials produce. After treatment:

  • 66% of the PRT group (33 of 50) were pain-free or nearly pain-free (reporting 0 or 1 on a 10-point scale).

  • 20% of the placebo group reached that level.

  • 10% of the usual-care group did.

Average pain scores dropped from roughly 4 out of 10 at baseline to 1.18 in the PRT group, compared with 2.84 in the placebo group and 3.13 in usual care — differences that were statistically significant (p < .001) and large by conventional standards (Hedges g of −1.14 vs. placebo and −1.75 vs. usual care).

Critically, the benefit wasn't a short-lived placebo bump. At one-year follow-up, the PRT group's average pain score was still 1.51, compared with 2.79 for placebo and 3.00 for usual care — again, a statistically significant, large difference (p ≤ .001).

The study also looked under the hood with fMRI brain scans, and found that after PRT, activity in brain regions tied to pain processing — the anterior insula and anterior midcingulate cortex — quieted down when patients were exposed to pain-inducing stimuli in the scanner. That matters because it suggests the effect isn't purely a change in how people report pain, but rather a change in how the brain actually processes it.

Does it last? The five-year follow-up

A therapy that works for a year but fades afterward is a different story than one that produces a lasting fix. In 2025, Ashar's team published a five-year follow-up of the same trial in JAMA Psychiatry, tracking down 113 of the original 151 participants (a 75% retention rate — quite good for a five-year window).

The results held up:

  • 55% of the original PRT group (21 of 38) were still nearly or completely pain-free five years later.

  • 26% of the placebo group (10 of 39) were.

  • 36% of the usual-care group (13 of 36) were.

As Ashar put it in Colorado's coverage of the study, "In the original trial, we showed that a lot of people got a lot better. And the five-year study shows they mainly stayed better" — without booster sessions or ongoing treatment.

The "why" behind the results

A separate analysis of the same trial data, published in JAMA Network Open, dug into the proposed mechanism: does it matter whether patients come to believe their pain is generated by the brain rather than by tissue damage? Before treatment, only about 10% of participants' explanations for their pain referenced the brain or mind. After PRT, that jumped to 51%, versus essentially no change in the control groups (effect sizes around g = 1.95–2.06). Patients who shifted their beliefs the most also tended to see the biggest reductions in pain, and that shift statistically explained part of PRT's overall effect — evidence that changing how people understand their pain is a real mechanism, not just a side effect of feeling better.

Where the skepticism comes in

None of this means PRT is beyond criticism, and a fair answer to "is it legit" has to include the pushback. Pain science writer Paul Ingraham, a frequent critic of overhyped chronic pain treatments, has argued (in a critique of the five-year follow-up) that the trial's framing oversells its numbers: the raw average difference in pain scores between PRT and placebo was well under a point on a 0–10 scale, and he contends the paper leans on standardized effect sizes (like Hedges g) partly to make a modest raw difference look more dramatic. He's also skeptical of a single, unreplicated trial from a single research group serving as the primary evidence base and wants to see independent replication before treating PRT as established.

That's a reasonable check on enthusiasm, and it's worth holding in mind. A few things temper it, though. The 0–10 point difference matters less than the categorical outcome most patients care about — whether their pain is essentially gone — and on that measure, PRT's advantage (66% vs. 10–20%) is not subtle. The effect also wasn't just self-report: it showed up in brain imaging, and it persisted five years out in a well-retained sample, which is a much higher bar than most psychological interventions are ever tested against. And PRT doesn't stand entirely alone — it builds on a broader, decades-old body of research on how belief, fear, and attention shape pain, including work on pain neuroscience education and related approaches such as Emotional Awareness and Expression Therapy. Independent replication in other labs and other pain conditions is the right thing to want next, and researchers themselves have said as much — but "not yet independently replicated" is a call for more evidence, not a reason to dismiss what's there.

So, is it legit?

For a specific population — people with chronic back pain that isn't explained by an ongoing structural problem — the evidence is genuinely stronger than a lot of what passes for chronic pain treatment, including many approaches with decades more history and marketing behind them. It has a real randomized controlled trial with an unusually rigorous placebo arm, effects large enough to be hard to explain away, corroborating brain imaging data, a plausible and separately tested mechanism, and results that held up five years later without any booster treatment.

It is not magic, it is not proven for every kind of pain, and it shouldn't be presented as a replacement for ruling out genuine structural or medical causes first. But as far as "is this real science or wishful thinking" — the Boulder Back Pain Study and its follow-up put PRT on much firmer ground than most alternative pain treatments ever reach.

Sources

Rick Hamman
Previous

Is Pain Reprocessing Therapy Right for Chronic Back Pain?
Next

Why Does Movement Hurt If I’m Not Injuring Myself?